^Authors:Maria Lettisia Meo¹, Didik Hasmono²

Department of Clinical Pharmacy, Faculty of Pharmacy,

Airlangga University, Surabaya, Indonesia

E-mail: gwae23@gmail.com

Abstract

Parkinson’s disease (PD) is the second most common neurodegenerative disease, exceeded only by Alzheimer’s disease (AD). Psychosis can be a major problem in Parkinson’s disease. Psychosis is a frequent complication of PD, and it is characterized mainly by visual hallucinations and delusions, which are often paranoid in flavor. Psychotic symptoms are present in up to 50% of patients with Parkinson’s disease. These symptoms have detrimental effects on patients’ and caregivers’ quality of life and may predict mortality. Psychosis (hallucinations and delusions) occurring in the context of Parkinson’s disease may be primary, reflecting a progression of the underlying disease process, or secondary to the use of dopaminomimetic drugs.  Attempts to reduce dopaminomimetic drugs or the initiation of antipsychotics can exacerbate motor symptoms in Parkinson’s disease with psychosis (hallucinations and dellusions). Psychosis in Parkinson’s disease (PDP) often responds to low doses of atypical neuroleptics  but adverse event but  the side effects and safety of each drugs should still be observe. Therefore the selection of appropriate therapy is expected to improve the quality of life of psychosis patients with Parkinson’s disease

Keywords: Antipsichosis, Parkinson Desease, Psychosis

Download 

Authors: Lucky Argasetya, Didik Hasmono, Suharjono Department of Clinical Pharmacy, Faculty of Pharmacy, Airlangga University Jalan Dharmawangsa Dalam, Surabaya 60286, East Java, Indonesia e... Read more

 Authors: Herni Setyawati1, Yulistiani2,3 1Magister Farmasi Klinik, Fakultas Farmasi Universitas Airlangga, Surabaya, Indonesia, 2Departemen Farmasi Klinik, Fakultas Farmasi Universitas Airl... Read more

Authors: Ana Nurlaili Hidayah1, Nurul Ma’rifah2, Widyanti Afifah3, Didik Hasmono4 1Master Program of Clinical Pharmacy, 3Master Program of Clinical Pharmacy, 4Faculty of Pharmacy, Airlangga... Read more

Authors: Diah Sri Ekawati1, Didik Hasmono2 Departement of Clinical Pharmacy, Faculty of Pharmacy,  Airlangga University Dharmawangsa Dalam, Surabaya, Indonesia Email: diahsrie@gmail.com Abst... Read more

Authors: Nurus Sobah1, Suharjono2* 1Master of Clinical Pharmacy, 2Department Of Clinical Pharmacy, Faculty of Pharmacy, Airlangga University, Surabaya, Indonesia Email: shj_ms_id@yahoo.co.id... Read more

Authors: Rezlie Bellatasie1, Wulan Panduwi Melasari1, Suharjono2* 1Master of Clinical Pharmacy, 2Department Of Clinical Pharmacy, Faculty of Pharmacy, Airlangga University, Surabaya, Indones... Read more

Authors: Wulan Panduwi Melasari1, Rezlie Bellatasie1,Suharjono2* 1Master of Clinical Pharmacy, 2Department Of Clinical Pharmacy, Faculty of Pharmacy, Airlangga University, Surabaya, Indonesi... Read more

Authors: Nurul Ma’rifah1*, Ana Nurlaili Hidayah2, Widyanti Afifah3, Didik Hasmono4 Department of Clinical Pharmacy, Faculty of Pharmacy, Airlangga University. Jalan Dharmawangsa Dalam, 60286... Read more